Trends in Liver Transplantation for Chronic Hepatitis B in an Era of Highly Potent Antiviral Therapies. - Suppr | 超能文献

Trends in Liver Transplantation for Chronic Hepatitis B in an Era of Highly Potent Antiviral Therapies.

作者信息

Fung James, Mak Lung-Yi, Chan Albert, Wong Tiffany, Dai Wing-Chiu, Sin Sui-Ling, She Wong-Hoi, Chu Ka-Wan, Ma Ka-Wing, Cheung Tan-To, Seto Wai-Kay, Yuen Man-Fung, Lo Chung-Mau

机构信息

Department of Medicine Queen Mary HospitalThe University of Hong Kong Pokfulam Hong Kong The Liver Transplant Center Queen Mary HospitalThe University of Hong Kong Pokfulam Hong Kong State Key Laboratory of Liver Research The University of Hong Kong Pokfulam Hong Kong Department of Surgery Queen Mary HospitalThe University of Hong Kong Pokfulam Hong Kong.

出版信息

Liver Transpl. 2021 Jan;27(1):134-139. doi: 10.1002/lt.25846. Epub 2020 Aug 20.

DOI:10.1002/lt.25846

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Trends in Liver Transplantation for Chronic Hepatitis B in an Era of Highly Potent Antiviral Therapies.

Liver Transpl. 2021 Jan;27(1):134-139. doi: 10.1002/lt.25846. Epub 2020 Aug 20.

2

Lamivudine for hepatitis B after liver transplantation.

Liver Transpl. 2001 Jun;7(6):511-2. doi: 10.1053/jlts.2001.24934.

3

Outcome of lamivudine resistant hepatitis B virus infection in liver transplant recipients in Singapore.

Gut. 2001 Apr;48(4):581. doi: 10.1136/gut.48.4.581.

4

A multicenter study of lamivudine treatment in 33 patients with hepatitis B after liver transplantation.

Liver Transpl. 2001 Jun;7(6):504-10. doi: 10.1053/jlts.2001.24896.

5

Antiviral combination therapy for lamivudine-resistant hepatitis B reinfection after liver transplantation.

Transpl Int. 2000;13 Suppl 1:S359-62. doi: 10.1007/s001470050361.

6

Management of viral hepatitis B.

J Gastroenterol Hepatol. 2002 Feb;17 Suppl:S125-45. doi: 10.1046/j.1440-1746.17.s1.3.x.

7

Outcome of lamivudine resistant hepatitis B virus infection in liver transplant recipients in Singapore.

Gut. 2000 Nov;47(5):741. doi: 10.1136/gut.47.5.741a.

8

Combination hepatitis B immune globulin and lamivudine versus hepatitis B immune globulin monotherapy in preventing recurrent hepatitis B virus infection in liver transplant recipients.

Transplant Proc. 2003 Mar;35(2):609-11. doi: 10.1016/s0041-1345(03)00008-3.

9

[Therapy of recurrent hepatitis B infection after liver transplantation. A retrospective analysis of 200 liver transplantations based on hepatitis B associated liver diseases].

Z Gastroenterol. 2000 Sep;38(9):773-83. doi: 10.1055/s-2000-7528.

10

Experience with lamivudine therapy for hepatitis B virus infection before and after liver transplantation, and review of the literature.

J Intern Med. 2003 May;253(5):544-52. doi: 10.1046/j.1365-2796.2003.01134.x.

引用本文的文献

1

Cost-Effectiveness of Universal Screen-and-Treat Strategies for Reducing Morbidity and Mortality of Chronic Hepatitis B in a High-Endemicity City.

J Viral Hepat. 2025 May;32(5):e70027. doi: 10.1111/jvh.70027.

2

Liver Transplantation: Contraindication and Ineligibility.

J Clin Exp Hepatol. 2023 Nov-Dec;13(6):1116-1129. doi: 10.1016/j.jceh.2023.04.005. Epub 2023 Apr 15.